158 related articles for article (PubMed ID: 28122352)
21. Disparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007.
Kwong SL; Stewart SL; Aoki CA; Chen MS
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2747-57. PubMed ID: 20823106
[TBL] [Abstract][Full Text] [Related]
22. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
[TBL] [Abstract][Full Text] [Related]
23. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
24. Increased long-term survival among patients with hepatocellular carcinoma after implementation of Model for End-stage Liver Disease score.
Wong RJ; Devaki P; Nguyen L; Cheung R; Cho-Phan C; Nguyen MH
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1534-40.e1. PubMed ID: 24361414
[TBL] [Abstract][Full Text] [Related]
25. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.
Davila JA; El-Serag HB
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):104-10; quiz 4-5. PubMed ID: 16431312
[TBL] [Abstract][Full Text] [Related]
26. Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma.
Mokdad AA; Murphy CC; Pruitt SL; Mansour JC; Marrero JA; Singal AG; Yopp AC
Cancer; 2018 Feb; 124(4):743-751. PubMed ID: 29072773
[TBL] [Abstract][Full Text] [Related]
27. Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States.
Rajbhandari R; Simon RE; Chung RT; Ananthakrishnan AN
Mayo Clin Proc; 2016 Sep; 91(9):1173-82. PubMed ID: 27497857
[TBL] [Abstract][Full Text] [Related]
28. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
29. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival.
Sloane D; Chen H; Howell C
J Natl Med Assoc; 2006 Dec; 98(12):1934-9. PubMed ID: 17225837
[TBL] [Abstract][Full Text] [Related]
30. Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Silva JP; Maurina MN; Tsai S; Christians KK; Clarke CN; Mogal H; Saeian K; Gamblin TC
J Am Coll Surg; 2019 Mar; 228(3):245-254. PubMed ID: 30639515
[TBL] [Abstract][Full Text] [Related]
31. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
[TBL] [Abstract][Full Text] [Related]
32. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
33. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.
Wong RJ; Devaki P; Nguyen L; Cheung R; Nguyen MH
Liver Transpl; 2014 May; 20(5):528-35. PubMed ID: 24415542
[TBL] [Abstract][Full Text] [Related]
34. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
35. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
Groeschl RT; Turaga KK; Gamblin TC
J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
[TBL] [Abstract][Full Text] [Related]
37. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA.
Tong MJ; Chavalitdhamrong D; Lu DS; Raman SS; Gomes A; Duffy JP; Hong JC; Busuttil RW
J Clin Gastroenterol; 2010 Mar; 44(3):e63-70. PubMed ID: 19745756
[TBL] [Abstract][Full Text] [Related]
38. Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival.
Soneji S; Tanner NT; Silvestri GA; Lathan CS; Black W
Chest; 2017 Sep; 152(3):587-597. PubMed ID: 28450031
[TBL] [Abstract][Full Text] [Related]
39. Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.
Parikh ND; Marshall VD; Singal AG; Nathan H; Lok AS; Balkrishnan R; Shahinian V
Hepatology; 2017 Jan; 65(1):122-133. PubMed ID: 27770556
[TBL] [Abstract][Full Text] [Related]
40. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
Robbins AS; Cox DD; Johnson LB; Ward EM
Cancer; 2011 Oct; 117(19):4531-9. PubMed ID: 21448933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
